Avion Pharmaceuticals, LLC and ROMEG Therapeutics, LLC finalize partnership agreement to license and commercialize Gloperba, a prophylactic treatment of gout in adults

ATLANTA, (July 16, 2019) – Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, has announced the license and commercialization agreement with ROMEG Therapeutics, LLC, for the exclusive rights to launch Gloperba – an oral solution for adults suffering from gout – in the United States. Gloperba is a new liquid oral ...

Read More

FDA Approval for GLOPERBA

ROMEG has received FDA approval for its product GLOPERBA®.   FOR IMMEDIATE RELEASE Contact: Greg Turner, Ball Consulting Group, LLC Phone: 617-243-9950 Email: greg@ballcg.com   ROMEG Therapeutics Receives FDA Approval of GLOPERBA® (colchicine) for Prophylaxis of Adult Gout Flares GLOPERBA® is the First FDA-approved Liquid Formulation for Prophylaxis of Gout Flares ...

Read More